University of South Florida, Psychiatry and Behavioral Neurosciences is a clinical research site located in Tampa, Florida, United States 33613.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
University of South Florida, Psychiatry and Behavioral Neurosciences has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Treatment Resistant Depression, Depressive Disorder, Major, Attention Deficit/Hyperactivity Disorder.
Sponsors: atai Therapeutics, Inc., Naurex, Inc, an affiliate of Allergan plc, Otsuka Pharmaceutical Development & Commercialization, Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of South Florida, Psychiatry and Behavioral Neurosciences has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of South Florida, Psychiatry and Behavioral Neurosciences has 3 clinical trials on record, with 2 currently active. Their work covers Treatment Resistant Depression, Depressive Disorder, Major, Attention Deficit/Hyperactivity Disorder.
University of South Florida, Psychiatry and Behavioral Neurosciences has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.